News|Videos|November 18, 2026

Loss of Measles Elimination Exposes MMR Gaps, Titer Testing Surges in Outbreak Areas

PAHO revoked the US measles elimination status this week. Nina Masters, PhD, MPH, offers commentary on the factors leading to it including vaccine hesitancy as well as unintended consequences such as the outbreak-driven spikes in measles titer testing among adults over 50.

This week, the Pan American Health Organization (PAHO) revoked the measles elimination status of the United States, ending a designation the country has held since 2000.¹ Nina Masters, PhD, MPH, principal applied research scientist at Truveta, a data and analytics company, said declining measles, mumps, and rubella (MMR) vaccination and clustered undervaccination drove the loss.

PAHO reached the decision after its regional re-verification commission met November 10-13, and determined measles transmission had continued for more than 12 months.¹ States reported 5,412 measles cases from January 2025 through November 13, 2026.⁴ Masters, who studied measles for her dissertation and previously worked at the Centers for Disease Control and Prevention, said losing elimination would have been unimaginable five to 10 years ago.

In a study published in JAMA Network Open, Masters and colleagues found on-time first-dose MMR vaccination fell from 79.9% in 2021 to 76.9% in 2024 among 321,743 children with regular access to care.³ Masters said these levels fall short of the immunity needed to prevent transmission, particularly where undervaccination clusters within communities. Her dissertation research examined how such pockets erode herd immunity and enable spread.

She identified vaccine hesitancy, compounded by proliferating misinformation, as the leading driver of the decline. Two doses of MMR are 97% effective against measles, and the rarity of disease in recent decades has made it easier for parents to dismiss the threat. Masters noted 10 measles deaths have occurred in the US this year.

“Vaccines are really a victim of their own success when vaccines are as effective as the MMR vaccine,” said Masters.

Outbreaks can still shift behavior. During the 2025 Texas outbreak, early MMR doses among infants aged six to 11 months rose from about 1% to about 20%, according to Truveta data Masters discussed. Most of these doses were given at six- and nine-month visits, which Masters described as key opportunities for pediatricians to discuss vaccination during an outbreak.

Measles Titers in Older Adults

Truveta Research analyzed adults over 50 years of age with an outpatient visit between January 2018 and March 2026, measuring the monthly rate of measles or MMR titer testing per 100,000 adults.² The investigators focused on this age group to limit prenatal rubella-related testing and to capture people seeking immunity testing long after childhood vaccination or infection.² Results were stratified by age group and urban or rural residence, with separate analyses for Texas and South Carolina.²

Nationally, titer testing averaged 40.9 per 100,000 adults per month in 2018 and peaked at 340.9 in 2025, a 734% increase.² In Texas, the 2025 rate peaked at 627.1, roughly 29-fold above baseline, while South Carolina reached 246.2 in 2026, a 10-fold increase over its 2021 baseline.² Urban residents consistently tested at higher rates than rural residents, and adults aged 50 to 59 years generally had the highest rates.²

Masters attributed the spikes to patient concern, clinician vigilance, exposure evaluation, and uncertainty about immunity status. Some older adults may also be seeking to protect grandchildren or immunocompromised family members.

“There’s a lot of different public health components going into why we’re seeing this spike in titer testing,” said Masters.

Masters noted adults born before 1957 are presumed immune, as are people with two doses of MMR, and the CDC does not recommend routine titer testing. Older adults who discover they lack immunity can receive an additional MMR dose. The Truveta findings are preliminary and not peer reviewed, and the authors cautioned the timing alignment with outbreaks does not prove causation.²

Canada, Spain, and the United Kingdom have also recently lost measles elimination status.¹ Masters said regaining US status will require closing immunity gaps, reversing the decline in vaccination, and maintaining strong surveillance to detect and contain outbreaks quickly.

References
  1. Reports say US loses measles elimination status after 26 years. Contagion. Published November 14, 2026. Accessed November 18, 2026. https://www.contagionlive.com/view/reports-say-us-loses-measles-elimination-status-after-26-years
  2. Truveta Research. Measles immunity testing among adults over 50 during outbreaks. Truveta. Published July 7, 2026. Accessed November 18, 2026. https://www.truveta.com/blog/research/measles-immunity-testing-adults-over-50-outbreaks/
  3. Parents who delay baby’s first vaccines also likely to skip measles shots. NBC News. Accessed November 18, 2026. https://www.nbcmiami.com/news/health/parents-delay-baby-first-vaccines-likely-skip-measles-shots/3742842/
  4. Measles elimination status: what it is and how the U.S. could lose it. KFF. Updated November 2026. Accessed November 18, 2026. https://www.kff.org/other-health/measles-elimination-status-what-it-is-and-how-the-u-s-could-lose-it/

Related to this article

Measles Update: November 13, 2026
The latest CDC numbers show a 4.4% increase of measles cases from week-to-week. Hospitalizations have reached 591, or 11% of all 2026 cases, and the Pan American Health Organization is deciding this week whether the United States has lost its measles elimination status.